Current therapy for metastatic head and neck cancer: evidence, opportunities, and challenges.
Management of metastatic head and neck squamous cell carcinoma is evolving as new
systemic therapies have led to improvements in survival, and as advances in locoregional …
systemic therapies have led to improvements in survival, and as advances in locoregional …
[HTML][HTML] Recent research on combination of radiotherapy with targeted therapy or immunotherapy in head and neck squamous cell carcinoma: a review for radiation …
Simple Summary Radiotherapy (RT) is an effective treatment for head and neck squamous
cell carcinoma (HNSCC). Concurrent RT with high dose cisplatin (100 mg/m2, days 1, 22 …
cell carcinoma (HNSCC). Concurrent RT with high dose cisplatin (100 mg/m2, days 1, 22 …
[HTML][HTML] Oligometastatic head and neck cancer: challenges and perspectives
Simple Summary Oligometastasis represents a disease state and an opportunity for cure
when metastases emerge. Emerging evidence supports that most head and neck cancer …
when metastases emerge. Emerging evidence supports that most head and neck cancer …
[HTML][HTML] Genomic and molecular profiling of human papillomavirus associated head and neck squamous cell carcinoma treated with immune checkpoint blockade …
Simple Summary The prognosis of recurrent and/or metastatic (R/M) head and neck
squamous cell carcinoma (HNSCC) remains poor. However, human papillomavirus (HPV) …
squamous cell carcinoma (HNSCC) remains poor. However, human papillomavirus (HPV) …
[HTML][HTML] Head and Neck Squamous Cell Carcinoma with Distant Metastasis: A Systematic Review and Meta-Analysis
A Daloiso, L Franz, T Mondello, M Tisato… - …, 2024 - pmc.ncbi.nlm.nih.gov
Abstract Background/Objectives: Distant metastasis (DM), though uncommon at initial
presentation, significantly worsens the prognosis of head and neck squamous cell …
presentation, significantly worsens the prognosis of head and neck squamous cell …
Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes
F Mattioli, A Lo Manto, M Miglio, E Serafini… - Head & …, 2023 - Wiley Online Library
Background Distant metastasis (DM) development in Oropharyngeal Squamous Cell
Carcinoma (OPSCC) represents an important prognostic factor. The identification of a …
Carcinoma (OPSCC) represents an important prognostic factor. The identification of a …
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed …
M Tonneau, R Nebbache, A Larnaudie, S Thureau… - Cancer …, 2024 - Elsevier
Head and neck carcinomas are initially metastatic in about 15% of cases. Radiotherapy is a
cornerstone in the multimodal strategy at the locoregional phase. In patients with head and …
cornerstone in the multimodal strategy at the locoregional phase. In patients with head and …
A multi-institutional analysis of outcomes following stereotactic body radiation therapy for management of metastases from squamous cell carcinomas of the head and …
Background There is limited data on clinical outcomes following SBRT for patients with
metastatic head and neck squamous cell carcinoma (mHNC). Method An international SBRT …
metastatic head and neck squamous cell carcinoma (mHNC). Method An international SBRT …
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal …
J Gaffney, A Ramzan, T Dinizulu, C Maley, O Onamusi… - Oral Oncology, 2024 - Elsevier
Objectives Emerging data supports radical intent therapy for oligometastatic (OM) relapsed
human papilloma virus (HPV+) related oropharyngeal cancer (OPC). We assess the …
human papilloma virus (HPV+) related oropharyngeal cancer (OPC). We assess the …
Managing recurrent metastatic head and neck cancer
H Shaikh, V Karivedu… - Hematology/Oncology …, 2021 - hemonc.theclinics.com
BACKGROUND Head and neck squamous cell carcinoma (HNSCC) is the sixth most
common cancer worldwide. 1 More than half of the patients with advanced stage disease …
common cancer worldwide. 1 More than half of the patients with advanced stage disease …